Title |
Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
|
---|---|
Published in |
Anais Brasileiros de Dermatologia, June 2015
|
DOI | 10.1590/abd1806-4841.20153113 |
Pubmed ID | |
Authors |
Patricia Shu Kurizky, Clarissa de Castro Ferreira, Lucas Souza Carmo Nogueira, Licia Maria Henrique da Mota |
Abstract |
Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a worldwide incidence of 2-3%. Fifty percent of patients are women, most still diagnosed during childbearing years. Currently,the estimate is that up to 107 thousand deliveries are performed annually in women with psoriasis, a percentage of them in women with moderate to severe disease. Fetal risks in pregnant women with psoriasis derive both from maternal disease and the medications used to control the illness. The purpose of this review is to study the effect of the main drugs used in the treatment of psoriasis and psoriatic arthritis during pregnancy and lactation, with particular focus on disease-modifying anti-rheumatic biological drugs, biological therapies, immunobiologics or biologics. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Saudi Arabia | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 131 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 20 | 15% |
Student > Master | 17 | 13% |
Student > Ph. D. Student | 17 | 13% |
Researcher | 13 | 10% |
Other | 11 | 8% |
Other | 21 | 16% |
Unknown | 32 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 51 | 39% |
Nursing and Health Professions | 13 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
Immunology and Microbiology | 6 | 5% |
Unspecified | 5 | 4% |
Other | 15 | 11% |
Unknown | 34 | 26% |